aetherAI vs Ibex Medical Analytics (2026)
Two computational pathology companies built outside the United States that both now hold permissions in more than one market. Ibex detects cancer, with prostate, breast and gastric solutions in routine clinical use, United States clearance as an in vitro diagnostic for the prostate product, peer reviewed publication and the most complete published certification set of any vendor in this index. aetherAI spans anatomical pathology and haematology, hosts third party algorithms alongside its own, and secured both a United States clearance and European certification for its image management platform in 2026. For a laboratory buying cancer detection with the strongest assurance record behind it, Ibex. For one wanting a platform that covers haematology as well and hosts other vendors' algorithms, aetherAI reaches wider. Check which permission applies in your market before either.
- The certification set is the most complete of any vendor in this index and the deployment evidence is verifiable through third parties rather than vendor claims.
- The cleared indication is conservative and well constructed, which is the right posture for software flagging cancer on a slide a pathologist will sign.
- Three cancer types are in routine clinical use worldwide with peer reviewed publication behind the deployment scale.
- It spans anatomical pathology and haematology rather than one domain, with training scale disclosed for the haematology product.
- The image management platform secured both a United States clearance and European certification in 2026, which is a genuine dual market position.
- The platform hosts diagnostic algorithms rather than only running its own, so a laboratory gets infrastructure and applications from one vendor.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. aetherAI and Ibex Medical Analytics are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | aetherAI | Ibex Medical Analytics |
|---|---|---|
| Primary category | Digital Pathology AI | Digital Pathology AI |
| Founded | 2016 | 2016 |
| Headquarters | Taipei, Taiwan | Tel Aviv, Israel |
| Website | aetherai.com | ibex-ai.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index records no top capability grade for aetherAI on any axis it scores. Set against Ibex Medical Analytics, aetherAI grades higher on EHR and Interoperability Depth. Its thinnest published disclosure sits on Model Supply Chain Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Ibex Medical Analytics its top capability grade on several axes, including AI Centrality, Autonomy and Oversight Model and Security Certifications and Trust Center. Set against aetherAI, Ibex Medical Analytics grades higher on several axes, including AI Centrality, Autonomy and Oversight Model and Model and Technology Transparency. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose aetherAI or Ibex Medical Analytics?
On the axes where the AI Health Index separates them, aetherAI grades higher on EHR and Interoperability Depth, and Ibex Medical Analytics grades higher on several axes, including AI Centrality, Autonomy and Oversight Model and Model and Technology Transparency. Ibex Medical Analytics leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do aetherAI and Ibex Medical Analytics differ most?
The widest separation the AI Health Index records between aetherAI and Ibex Medical Analytics is on Deployment Model and Data Residency, where aetherAI grades C and Ibex Medical Analytics grades A. That axis sits in the Integration and Deployment group, so it should carry the most weight for a buyer whose binding constraint is how the product lands in the stack already in place.
Where do aetherAI and Ibex Medical Analytics grade the same?
The AI Health Index grades aetherAI and Ibex Medical Analytics the same on several axes, including HIPAA and BAA Posture, AI Governance and Bias Disclosure and Commercial Transparency. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have aetherAI and Ibex Medical Analytics not disclosed?
At the last review, at least one of aetherAI and Ibex Medical Analytics published thin or absent detail on Model Supply Chain Disclosure. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.
Read the regulatory footprint by market rather than by company, since a product usable for diagnosis in one jurisdiction may be research use only in another, and both vendors hold different permissions in different places. aetherAI publishes no health privacy statement, business associate terms, hosting detail or subgroup analysis. Neither vendor imposes a published performance requirement on third party algorithms it distributes. Staining and scanner variation between laboratories remains the largest uncontrolled variable for any model either platform runs.